Senior Manager, Clinical Sourcing and Contract Management at Abata Therapeutics

Burlington, Massachusetts, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor’s degree in life sciences, business administration, or a related field; advanced degree a plus
  • 10+ years of experience in business operations or as a contract/vendor manager in the biotech or pharmaceutical industry
  • Strong understanding of clinical trial vendor categories and contracting processes
  • Experience managing RFPs, contracts, and vendors in a cross-functional environment

Responsibilities

  • Strategically lead and manage the end-to-end RFP process for clinical vendors (e.g., CROs, advertising partners, laboratories), including the development of RFP documentation, cross-functional evaluation of proposals, coordination of bid defense meetings, and driving informed vendor selection decisions in alignment with program and study goals
  • Oversee vendor onboarding and contracting activities in partnership with Legal, Clinical Operations, and other internal stakeholders, ensuring contract execution aligns with clinical development timelines and organizational risk tolerance
  • Lead high-level contract negotiations with clinical vendors and investigative sites, balancing speed, cost, quality, compliance, and risk. Escalate and resolve complex issues applying strategic insight and operation savvy
  • Own and optimize vendor and contract tracking infrastructure, ensuring visibility, data integrity, and cross-functional alignment through regular reporting and stakeholder engagement
  • Serve as the senior vendor management partner for Clinical Operations, providing leadership in budget alignment, commitment tracking, while maintaining vendor records in accordance with internal financial compliance standards
  • Collaborate closely with Clinical Operations, Finance, and Program Management to inform strategic budget planning, financial forecasting, and oversight of vendor invoice reconciliation and accrual processes. Provide finance with timely updates on contractual changes throughout the clinical trial lifecycle
  • Develop and maintain strong, performance-driven vendor partnerships, establish KPIs, monitor service delivery, and ensure accountability and continuous improvement throughout the life of each engagement. Cultivate strategic connections with business development counterparts at each vendor
  • Lead cross-functional process improvement initiatives, focusing on operational scalability, risk reduction, and increased efficiency across vendor management and internal workflows
  • Provide mentorship and day-to-day guidance to junior team members, supporting their professional development and contributing to a collaborative team culture
  • Design, implement, and maintain SOPs, work instructions, and standardized tools to support best practices in vendor selection, RFPs, contracting, and ongoing vendor oversight as needed

Skills

RFP
Vendor Management
Contract Negotiation
CRO Management
Vendor Onboarding
Clinical Sourcing
Contract Management
Bid Evaluation

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI